nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—ADRB1—coronary artery disease	0.136	0.543	CbGaD
Salbutamol—ADRB2—coronary artery disease	0.114	0.457	CbGaD
Salbutamol—Bupranolol—Gemfibrozil—coronary artery disease	0.101	0.285	CrCrCtD
Salbutamol—Levobunolol—Timolol—coronary artery disease	0.052	0.146	CrCrCtD
Salbutamol—ADRB2—Penbutolol—coronary artery disease	0.0496	0.194	CbGbCtD
Salbutamol—ADRB1—Penbutolol—coronary artery disease	0.0489	0.191	CbGbCtD
Salbutamol—Levobunolol—Penbutolol—coronary artery disease	0.0442	0.124	CrCrCtD
Salbutamol—Carteolol—Penbutolol—coronary artery disease	0.0442	0.124	CrCrCtD
Salbutamol—Nadolol—Penbutolol—coronary artery disease	0.0442	0.124	CrCrCtD
Salbutamol—Bupranolol—Timolol—coronary artery disease	0.0376	0.106	CrCrCtD
Salbutamol—ADRB2—Timolol—coronary artery disease	0.035	0.137	CbGbCtD
Salbutamol—ADRB1—Timolol—coronary artery disease	0.0344	0.135	CbGbCtD
Salbutamol—Bupranolol—Penbutolol—coronary artery disease	0.0319	0.0898	CrCrCtD
Salbutamol—CYP3A4—Ticagrelor—coronary artery disease	0.0128	0.0501	CbGbCtD
Salbutamol—CYP3A4—Fenofibrate—coronary artery disease	0.0114	0.0447	CbGbCtD
Salbutamol—CYP3A4—Gemfibrozil—coronary artery disease	0.00913	0.0357	CbGbCtD
Salbutamol—CYP3A4—Clopidogrel—coronary artery disease	0.00791	0.031	CbGbCtD
Salbutamol—CYP3A4—Eplerenone—coronary artery disease	0.00736	0.0288	CbGbCtD
Salbutamol—CYP3A4—Enalapril—coronary artery disease	0.00656	0.0257	CbGbCtD
Salbutamol—CYP3A4—Rosuvastatin—coronary artery disease	0.0051	0.02	CbGbCtD
Salbutamol—CYP3A4—Ezetimibe—coronary artery disease	0.0051	0.02	CbGbCtD
Salbutamol—CYP3A4—Simvastatin—coronary artery disease	0.00474	0.0186	CbGbCtD
Salbutamol—CYP3A4—Pravastatin—coronary artery disease	0.00464	0.0182	CbGbCtD
Salbutamol—CYP3A4—Lovastatin—coronary artery disease	0.00464	0.0182	CbGbCtD
Salbutamol—CYP3A4—Atorvastatin—coronary artery disease	0.00423	0.0165	CbGbCtD
Salbutamol—CYP3A4—Losartan—coronary artery disease	0.00386	0.0151	CbGbCtD
Salbutamol—Isoprenaline—MAPK1—coronary artery disease	0.000199	0.0709	CrCbGaD
Salbutamol—Pirbuterol—ADRB1—coronary artery disease	0.000182	0.0649	CrCbGaD
Salbutamol—Levobunolol—ADRB1—coronary artery disease	0.000163	0.0578	CrCbGaD
Salbutamol—Pirbuterol—ADRB2—coronary artery disease	0.000153	0.0546	CrCbGaD
Salbutamol—Isoetarine—ADRB1—coronary artery disease	0.000143	0.0509	CrCbGaD
Salbutamol—Carteolol—ADRB1—coronary artery disease	0.000138	0.0492	CrCbGaD
Salbutamol—Levobunolol—ADRB2—coronary artery disease	0.000137	0.0486	CrCbGaD
Salbutamol—Terbutaline—ADRB2—coronary artery disease	0.000125	0.0445	CrCbGaD
Salbutamol—Nadolol—ADRB1—coronary artery disease	0.000123	0.0438	CrCbGaD
Salbutamol—Isoetarine—ADRB2—coronary artery disease	0.00012	0.0428	CrCbGaD
Salbutamol—Clenbuterol—ADRB1—coronary artery disease	0.000119	0.0423	CrCbGaD
Salbutamol—Bupranolol—ADRB1—coronary artery disease	0.000118	0.0418	CrCbGaD
Salbutamol—Carteolol—ADRB2—coronary artery disease	0.000116	0.0414	CrCbGaD
Salbutamol—Clenbuterol—TNF—coronary artery disease	0.000113	0.0401	CrCbGaD
Salbutamol—Salmeterol—ADRB2—coronary artery disease	0.000106	0.0378	CrCbGaD
Salbutamol—Nadolol—ADRB2—coronary artery disease	0.000104	0.0369	CrCbGaD
Salbutamol—Norepinephrine—SLC22A3—coronary artery disease	0.000101	0.036	CrCbGaD
Salbutamol—Clenbuterol—ADRB2—coronary artery disease	0.0001	0.0356	CrCbGaD
Salbutamol—Bupranolol—ADRB2—coronary artery disease	9.88e-05	0.0352	CrCbGaD
Salbutamol—Isoprenaline—ADRB1—coronary artery disease	5.94e-05	0.0211	CrCbGaD
Salbutamol—Norepinephrine—ADRB1—coronary artery disease	5.5e-05	0.0196	CrCbGaD
Salbutamol—Isoprenaline—ADRB2—coronary artery disease	5e-05	0.0178	CrCbGaD
Salbutamol—Epinephrine—ADRB1—coronary artery disease	4.99e-05	0.0178	CrCbGaD
Salbutamol—Epinephrine—TNF—coronary artery disease	4.74e-05	0.0169	CrCbGaD
Salbutamol—Norepinephrine—ADRB2—coronary artery disease	4.63e-05	0.0165	CrCbGaD
Salbutamol—Epinephrine—ADRB2—coronary artery disease	4.2e-05	0.0149	CrCbGaD
Salbutamol—Rash—Ezetimibe—coronary artery disease	2.98e-05	0.000272	CcSEcCtD
Salbutamol—Dermatitis—Ezetimibe—coronary artery disease	2.98e-05	0.000271	CcSEcCtD
Salbutamol—Discomfort—Timolol—coronary artery disease	2.98e-05	0.000271	CcSEcCtD
Salbutamol—Asthenia—Niacin—coronary artery disease	2.97e-05	0.000271	CcSEcCtD
Salbutamol—Fatigue—Losartan—coronary artery disease	2.97e-05	0.00027	CcSEcCtD
Salbutamol—Headache—Ezetimibe—coronary artery disease	2.96e-05	0.00027	CcSEcCtD
Salbutamol—Malaise—Lisinopril—coronary artery disease	2.96e-05	0.000269	CcSEcCtD
Salbutamol—Oedema—Ramipril—coronary artery disease	2.95e-05	0.000269	CcSEcCtD
Salbutamol—Anaphylactic shock—Ramipril—coronary artery disease	2.95e-05	0.000269	CcSEcCtD
Salbutamol—Vertigo—Lisinopril—coronary artery disease	2.95e-05	0.000268	CcSEcCtD
Salbutamol—Dry mouth—Timolol—coronary artery disease	2.95e-05	0.000268	CcSEcCtD
Salbutamol—Pain—Losartan—coronary artery disease	2.95e-05	0.000268	CcSEcCtD
Salbutamol—Constipation—Losartan—coronary artery disease	2.95e-05	0.000268	CcSEcCtD
Salbutamol—Syncope—Lisinopril—coronary artery disease	2.94e-05	0.000268	CcSEcCtD
Salbutamol—Vomiting—Eplerenone—coronary artery disease	2.94e-05	0.000268	CcSEcCtD
Salbutamol—Feeling abnormal—Furosemide—coronary artery disease	2.94e-05	0.000268	CcSEcCtD
Salbutamol—Nausea—Fenofibrate—coronary artery disease	2.93e-05	0.000267	CcSEcCtD
Salbutamol—Pruritus—Niacin—coronary artery disease	2.93e-05	0.000267	CcSEcCtD
Salbutamol—Asthenia—Pravastatin—coronary artery disease	2.93e-05	0.000266	CcSEcCtD
Salbutamol—Gastrointestinal pain—Furosemide—coronary artery disease	2.92e-05	0.000266	CcSEcCtD
Salbutamol—Rash—Eplerenone—coronary artery disease	2.92e-05	0.000266	CcSEcCtD
Salbutamol—Urticaria—Perindopril—coronary artery disease	2.92e-05	0.000266	CcSEcCtD
Salbutamol—Hypersensitivity—Trandolapril—coronary artery disease	2.92e-05	0.000266	CcSEcCtD
Salbutamol—Dermatitis—Eplerenone—coronary artery disease	2.92e-05	0.000265	CcSEcCtD
Salbutamol—Diarrhoea—Valsartan—coronary artery disease	2.92e-05	0.000265	CcSEcCtD
Salbutamol—Shock—Ramipril—coronary artery disease	2.91e-05	0.000265	CcSEcCtD
Salbutamol—Hypersensitivity—Enalapril—coronary artery disease	2.91e-05	0.000265	CcSEcCtD
Salbutamol—Abdominal pain—Perindopril—coronary artery disease	2.9e-05	0.000264	CcSEcCtD
Salbutamol—Body temperature increased—Perindopril—coronary artery disease	2.9e-05	0.000264	CcSEcCtD
Salbutamol—Palpitations—Lisinopril—coronary artery disease	2.9e-05	0.000264	CcSEcCtD
Salbutamol—Diarrhoea—Olmesartan—coronary artery disease	2.9e-05	0.000264	CcSEcCtD
Salbutamol—Headache—Eplerenone—coronary artery disease	2.9e-05	0.000264	CcSEcCtD
Salbutamol—Nervous system disorder—Ramipril—coronary artery disease	2.9e-05	0.000264	CcSEcCtD
Salbutamol—Anaphylactic shock—Timolol—coronary artery disease	2.89e-05	0.000263	CcSEcCtD
Salbutamol—Oedema—Timolol—coronary artery disease	2.89e-05	0.000263	CcSEcCtD
Salbutamol—Pruritus—Pravastatin—coronary artery disease	2.89e-05	0.000263	CcSEcCtD
Salbutamol—Loss of consciousness—Lisinopril—coronary artery disease	2.89e-05	0.000263	CcSEcCtD
Salbutamol—Nausea—Clopidogrel—coronary artery disease	2.88e-05	0.000263	CcSEcCtD
Salbutamol—Tachycardia—Ramipril—coronary artery disease	2.88e-05	0.000262	CcSEcCtD
Salbutamol—Skin disorder—Ramipril—coronary artery disease	2.87e-05	0.000261	CcSEcCtD
Salbutamol—Infection—Timolol—coronary artery disease	2.87e-05	0.000261	CcSEcCtD
Salbutamol—Vomiting—Simvastatin—coronary artery disease	2.87e-05	0.000261	CcSEcCtD
Salbutamol—Hypersensitivity—Telmisartan—coronary artery disease	2.87e-05	0.000261	CcSEcCtD
Salbutamol—Cough—Lisinopril—coronary artery disease	2.87e-05	0.000261	CcSEcCtD
Salbutamol—Nausea—Lovastatin—coronary artery disease	2.87e-05	0.000261	CcSEcCtD
Salbutamol—Hyperhidrosis—Ramipril—coronary artery disease	2.86e-05	0.00026	CcSEcCtD
Salbutamol—Rash—Simvastatin—coronary artery disease	2.84e-05	0.000259	CcSEcCtD
Salbutamol—Dermatitis—Simvastatin—coronary artery disease	2.84e-05	0.000259	CcSEcCtD
Salbutamol—Asthenia—Trandolapril—coronary artery disease	2.84e-05	0.000259	CcSEcCtD
Salbutamol—Shock—Timolol—coronary artery disease	2.84e-05	0.000259	CcSEcCtD
Salbutamol—Feeling abnormal—Losartan—coronary artery disease	2.84e-05	0.000258	CcSEcCtD
Salbutamol—Urticaria—Furosemide—coronary artery disease	2.84e-05	0.000258	CcSEcCtD
Salbutamol—Diarrhoea—Niacin—coronary artery disease	2.83e-05	0.000258	CcSEcCtD
Salbutamol—Nervous system disorder—Timolol—coronary artery disease	2.83e-05	0.000258	CcSEcCtD
Salbutamol—Asthenia—Enalapril—coronary artery disease	2.83e-05	0.000258	CcSEcCtD
Salbutamol—Headache—Simvastatin—coronary artery disease	2.83e-05	0.000257	CcSEcCtD
Salbutamol—Body temperature increased—Furosemide—coronary artery disease	2.82e-05	0.000257	CcSEcCtD
Salbutamol—Abdominal pain—Furosemide—coronary artery disease	2.82e-05	0.000257	CcSEcCtD
Salbutamol—Gastrointestinal pain—Losartan—coronary artery disease	2.82e-05	0.000256	CcSEcCtD
Salbutamol—Dizziness—Valsartan—coronary artery disease	2.82e-05	0.000256	CcSEcCtD
Salbutamol—Anorexia—Ramipril—coronary artery disease	2.82e-05	0.000256	CcSEcCtD
Salbutamol—Nausea—Ezetimibe—coronary artery disease	2.81e-05	0.000256	CcSEcCtD
Salbutamol—Skin disorder—Timolol—coronary artery disease	2.81e-05	0.000255	CcSEcCtD
Salbutamol—Dizziness—Olmesartan—coronary artery disease	2.8e-05	0.000255	CcSEcCtD
Salbutamol—Pruritus—Trandolapril—coronary artery disease	2.8e-05	0.000255	CcSEcCtD
Salbutamol—Arthralgia—Lisinopril—coronary artery disease	2.8e-05	0.000254	CcSEcCtD
Salbutamol—Chest pain—Lisinopril—coronary artery disease	2.8e-05	0.000254	CcSEcCtD
Salbutamol—Myalgia—Lisinopril—coronary artery disease	2.8e-05	0.000254	CcSEcCtD
Salbutamol—Hyperhidrosis—Timolol—coronary artery disease	2.79e-05	0.000254	CcSEcCtD
Salbutamol—Asthenia—Telmisartan—coronary artery disease	2.79e-05	0.000254	CcSEcCtD
Salbutamol—Pruritus—Enalapril—coronary artery disease	2.79e-05	0.000254	CcSEcCtD
Salbutamol—Diarrhoea—Pravastatin—coronary artery disease	2.79e-05	0.000254	CcSEcCtD
Salbutamol—Anxiety—Lisinopril—coronary artery disease	2.79e-05	0.000254	CcSEcCtD
Salbutamol—Discomfort—Lisinopril—coronary artery disease	2.76e-05	0.000251	CcSEcCtD
Salbutamol—Hypotension—Ramipril—coronary artery disease	2.76e-05	0.000251	CcSEcCtD
Salbutamol—Anorexia—Timolol—coronary artery disease	2.75e-05	0.000251	CcSEcCtD
Salbutamol—Pruritus—Telmisartan—coronary artery disease	2.75e-05	0.000251	CcSEcCtD
Salbutamol—Nausea—Eplerenone—coronary artery disease	2.75e-05	0.00025	CcSEcCtD
Salbutamol—Dizziness—Niacin—coronary artery disease	2.74e-05	0.000249	CcSEcCtD
Salbutamol—Urticaria—Losartan—coronary artery disease	2.74e-05	0.000249	CcSEcCtD
Salbutamol—Dry mouth—Lisinopril—coronary artery disease	2.73e-05	0.000249	CcSEcCtD
Salbutamol—Abdominal pain—Losartan—coronary artery disease	2.72e-05	0.000248	CcSEcCtD
Salbutamol—Body temperature increased—Losartan—coronary artery disease	2.72e-05	0.000248	CcSEcCtD
Salbutamol—Asthenia—Captopril—coronary artery disease	2.71e-05	0.000247	CcSEcCtD
Salbutamol—Diarrhoea—Trandolapril—coronary artery disease	2.71e-05	0.000247	CcSEcCtD
Salbutamol—Vomiting—Valsartan—coronary artery disease	2.71e-05	0.000247	CcSEcCtD
Salbutamol—Diarrhoea—Enalapril—coronary artery disease	2.7e-05	0.000246	CcSEcCtD
Salbutamol—Hypotension—Timolol—coronary artery disease	2.7e-05	0.000246	CcSEcCtD
Salbutamol—Dizziness—Pravastatin—coronary artery disease	2.7e-05	0.000246	CcSEcCtD
Salbutamol—Vomiting—Olmesartan—coronary artery disease	2.7e-05	0.000245	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.69e-05	0.000245	CcSEcCtD
Salbutamol—Rash—Valsartan—coronary artery disease	2.69e-05	0.000245	CcSEcCtD
Salbutamol—Dermatitis—Valsartan—coronary artery disease	2.68e-05	0.000244	CcSEcCtD
Salbutamol—Nausea—Simvastatin—coronary artery disease	2.68e-05	0.000244	CcSEcCtD
Salbutamol—Anaphylactic shock—Lisinopril—coronary artery disease	2.68e-05	0.000244	CcSEcCtD
Salbutamol—Oedema—Lisinopril—coronary artery disease	2.68e-05	0.000244	CcSEcCtD
Salbutamol—Pruritus—Captopril—coronary artery disease	2.68e-05	0.000244	CcSEcCtD
Salbutamol—Rash—Olmesartan—coronary artery disease	2.67e-05	0.000243	CcSEcCtD
Salbutamol—Insomnia—Ramipril—coronary artery disease	2.67e-05	0.000243	CcSEcCtD
Salbutamol—Dermatitis—Olmesartan—coronary artery disease	2.67e-05	0.000243	CcSEcCtD
Salbutamol—Headache—Valsartan—coronary artery disease	2.67e-05	0.000243	CcSEcCtD
Salbutamol—Diarrhoea—Telmisartan—coronary artery disease	2.66e-05	0.000242	CcSEcCtD
Salbutamol—Infection—Lisinopril—coronary artery disease	2.66e-05	0.000242	CcSEcCtD
Salbutamol—Headache—Olmesartan—coronary artery disease	2.66e-05	0.000242	CcSEcCtD
Salbutamol—Paraesthesia—Ramipril—coronary artery disease	2.65e-05	0.000241	CcSEcCtD
Salbutamol—Shock—Lisinopril—coronary artery disease	2.64e-05	0.00024	CcSEcCtD
Salbutamol—Asthenia—Perindopril—coronary artery disease	2.64e-05	0.00024	CcSEcCtD
Salbutamol—Dyspnoea—Ramipril—coronary artery disease	2.63e-05	0.00024	CcSEcCtD
Salbutamol—Vomiting—Niacin—coronary artery disease	2.63e-05	0.00024	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Timolol—coronary artery disease	2.63e-05	0.00024	CcSEcCtD
Salbutamol—Hypersensitivity—Furosemide—coronary artery disease	2.63e-05	0.000239	CcSEcCtD
Salbutamol—Somnolence—Ramipril—coronary artery disease	2.63e-05	0.000239	CcSEcCtD
Salbutamol—Dizziness—Trandolapril—coronary artery disease	2.62e-05	0.000238	CcSEcCtD
Salbutamol—Tachycardia—Lisinopril—coronary artery disease	2.62e-05	0.000238	CcSEcCtD
Salbutamol—Insomnia—Timolol—coronary artery disease	2.61e-05	0.000238	CcSEcCtD
Salbutamol—Rash—Niacin—coronary artery disease	2.61e-05	0.000238	CcSEcCtD
Salbutamol—Dermatitis—Niacin—coronary artery disease	2.61e-05	0.000238	CcSEcCtD
Salbutamol—Dizziness—Enalapril—coronary artery disease	2.61e-05	0.000237	CcSEcCtD
Salbutamol—Skin disorder—Lisinopril—coronary artery disease	2.6e-05	0.000237	CcSEcCtD
Salbutamol—Dyspepsia—Ramipril—coronary artery disease	2.6e-05	0.000237	CcSEcCtD
Salbutamol—Pruritus—Perindopril—coronary artery disease	2.6e-05	0.000237	CcSEcCtD
Salbutamol—Headache—Niacin—coronary artery disease	2.6e-05	0.000236	CcSEcCtD
Salbutamol—Paraesthesia—Timolol—coronary artery disease	2.59e-05	0.000236	CcSEcCtD
Salbutamol—Vomiting—Pravastatin—coronary artery disease	2.59e-05	0.000236	CcSEcCtD
Salbutamol—Hyperhidrosis—Lisinopril—coronary artery disease	2.59e-05	0.000236	CcSEcCtD
Salbutamol—Diarrhoea—Captopril—coronary artery disease	2.59e-05	0.000236	CcSEcCtD
Salbutamol—Dyspnoea—Timolol—coronary artery disease	2.58e-05	0.000234	CcSEcCtD
Salbutamol—Dizziness—Telmisartan—coronary artery disease	2.57e-05	0.000234	CcSEcCtD
Salbutamol—Rash—Pravastatin—coronary artery disease	2.57e-05	0.000234	CcSEcCtD
Salbutamol—Dermatitis—Pravastatin—coronary artery disease	2.57e-05	0.000234	CcSEcCtD
Salbutamol—Decreased appetite—Ramipril—coronary artery disease	2.57e-05	0.000234	CcSEcCtD
Salbutamol—Somnolence—Timolol—coronary artery disease	2.57e-05	0.000234	CcSEcCtD
Salbutamol—Asthenia—Furosemide—coronary artery disease	2.56e-05	0.000233	CcSEcCtD
Salbutamol—Headache—Pravastatin—coronary artery disease	2.56e-05	0.000233	CcSEcCtD
Salbutamol—Anorexia—Lisinopril—coronary artery disease	2.55e-05	0.000232	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Ramipril—coronary artery disease	2.55e-05	0.000232	CcSEcCtD
Salbutamol—Fatigue—Ramipril—coronary artery disease	2.55e-05	0.000232	CcSEcCtD
Salbutamol—Dyspepsia—Timolol—coronary artery disease	2.54e-05	0.000231	CcSEcCtD
Salbutamol—Hypersensitivity—Losartan—coronary artery disease	2.54e-05	0.000231	CcSEcCtD
Salbutamol—Nausea—Valsartan—coronary artery disease	2.53e-05	0.00023	CcSEcCtD
Salbutamol—Pruritus—Furosemide—coronary artery disease	2.53e-05	0.00023	CcSEcCtD
Salbutamol—Constipation—Ramipril—coronary artery disease	2.53e-05	0.00023	CcSEcCtD
Salbutamol—Nausea—Olmesartan—coronary artery disease	2.52e-05	0.000229	CcSEcCtD
Salbutamol—Vomiting—Trandolapril—coronary artery disease	2.52e-05	0.000229	CcSEcCtD
Salbutamol—Diarrhoea—Perindopril—coronary artery disease	2.51e-05	0.000229	CcSEcCtD
Salbutamol—Decreased appetite—Timolol—coronary artery disease	2.51e-05	0.000229	CcSEcCtD
Salbutamol—Vomiting—Enalapril—coronary artery disease	2.51e-05	0.000228	CcSEcCtD
Salbutamol—Hypotension—Lisinopril—coronary artery disease	2.5e-05	0.000228	CcSEcCtD
Salbutamol—Dizziness—Captopril—coronary artery disease	2.5e-05	0.000228	CcSEcCtD
Salbutamol—Rash—Trandolapril—coronary artery disease	2.5e-05	0.000227	CcSEcCtD
Salbutamol—Dermatitis—Trandolapril—coronary artery disease	2.5e-05	0.000227	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Timolol—coronary artery disease	2.49e-05	0.000227	CcSEcCtD
Salbutamol—Fatigue—Timolol—coronary artery disease	2.49e-05	0.000227	CcSEcCtD
Salbutamol—Rash—Enalapril—coronary artery disease	2.49e-05	0.000226	CcSEcCtD
Salbutamol—Dermatitis—Enalapril—coronary artery disease	2.49e-05	0.000226	CcSEcCtD
Salbutamol—Headache—Trandolapril—coronary artery disease	2.48e-05	0.000226	CcSEcCtD
Salbutamol—Vomiting—Telmisartan—coronary artery disease	2.47e-05	0.000225	CcSEcCtD
Salbutamol—Asthenia—Losartan—coronary artery disease	2.47e-05	0.000225	CcSEcCtD
Salbutamol—Headache—Enalapril—coronary artery disease	2.47e-05	0.000225	CcSEcCtD
Salbutamol—Pain—Timolol—coronary artery disease	2.47e-05	0.000225	CcSEcCtD
Salbutamol—Nausea—Niacin—coronary artery disease	2.46e-05	0.000224	CcSEcCtD
Salbutamol—Rash—Telmisartan—coronary artery disease	2.45e-05	0.000223	CcSEcCtD
Salbutamol—Dermatitis—Telmisartan—coronary artery disease	2.45e-05	0.000223	CcSEcCtD
Salbutamol—Diarrhoea—Furosemide—coronary artery disease	2.44e-05	0.000222	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.44e-05	0.000222	CcSEcCtD
Salbutamol—Pruritus—Losartan—coronary artery disease	2.44e-05	0.000222	CcSEcCtD
Salbutamol—Headache—Telmisartan—coronary artery disease	2.44e-05	0.000222	CcSEcCtD
Salbutamol—Feeling abnormal—Ramipril—coronary artery disease	2.43e-05	0.000222	CcSEcCtD
Salbutamol—Dizziness—Perindopril—coronary artery disease	2.43e-05	0.000221	CcSEcCtD
Salbutamol—Insomnia—Lisinopril—coronary artery disease	2.42e-05	0.000221	CcSEcCtD
Salbutamol—Nausea—Pravastatin—coronary artery disease	2.42e-05	0.000221	CcSEcCtD
Salbutamol—Gastrointestinal pain—Ramipril—coronary artery disease	2.42e-05	0.00022	CcSEcCtD
Salbutamol—Paraesthesia—Lisinopril—coronary artery disease	2.41e-05	0.000219	CcSEcCtD
Salbutamol—Vomiting—Captopril—coronary artery disease	2.41e-05	0.000219	CcSEcCtD
Salbutamol—Dyspnoea—Lisinopril—coronary artery disease	2.39e-05	0.000217	CcSEcCtD
Salbutamol—Rash—Captopril—coronary artery disease	2.39e-05	0.000217	CcSEcCtD
Salbutamol—Dermatitis—Captopril—coronary artery disease	2.38e-05	0.000217	CcSEcCtD
Salbutamol—Somnolence—Lisinopril—coronary artery disease	2.38e-05	0.000217	CcSEcCtD
Salbutamol—Feeling abnormal—Timolol—coronary artery disease	2.38e-05	0.000217	CcSEcCtD
Salbutamol—Headache—Captopril—coronary artery disease	2.37e-05	0.000216	CcSEcCtD
Salbutamol—Gastrointestinal pain—Timolol—coronary artery disease	2.36e-05	0.000215	CcSEcCtD
Salbutamol—Dizziness—Furosemide—coronary artery disease	2.36e-05	0.000215	CcSEcCtD
Salbutamol—Dyspepsia—Lisinopril—coronary artery disease	2.36e-05	0.000215	CcSEcCtD
Salbutamol—Diarrhoea—Losartan—coronary artery disease	2.36e-05	0.000215	CcSEcCtD
Salbutamol—Nausea—Trandolapril—coronary artery disease	2.35e-05	0.000214	CcSEcCtD
Salbutamol—Urticaria—Ramipril—coronary artery disease	2.35e-05	0.000214	CcSEcCtD
Salbutamol—Nausea—Enalapril—coronary artery disease	2.34e-05	0.000213	CcSEcCtD
Salbutamol—Vomiting—Perindopril—coronary artery disease	2.34e-05	0.000213	CcSEcCtD
Salbutamol—Body temperature increased—Ramipril—coronary artery disease	2.34e-05	0.000213	CcSEcCtD
Salbutamol—Abdominal pain—Ramipril—coronary artery disease	2.34e-05	0.000213	CcSEcCtD
Salbutamol—Decreased appetite—Lisinopril—coronary artery disease	2.33e-05	0.000212	CcSEcCtD
Salbutamol—Rash—Perindopril—coronary artery disease	2.32e-05	0.000211	CcSEcCtD
Salbutamol—Dermatitis—Perindopril—coronary artery disease	2.31e-05	0.000211	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.31e-05	0.000211	CcSEcCtD
Salbutamol—Nausea—Telmisartan—coronary artery disease	2.31e-05	0.00021	CcSEcCtD
Salbutamol—Fatigue—Lisinopril—coronary artery disease	2.31e-05	0.00021	CcSEcCtD
Salbutamol—Headache—Perindopril—coronary artery disease	2.3e-05	0.000209	CcSEcCtD
Salbutamol—Urticaria—Timolol—coronary artery disease	2.29e-05	0.000209	CcSEcCtD
Salbutamol—Pain—Lisinopril—coronary artery disease	2.29e-05	0.000209	CcSEcCtD
Salbutamol—Constipation—Lisinopril—coronary artery disease	2.29e-05	0.000209	CcSEcCtD
Salbutamol—Abdominal pain—Timolol—coronary artery disease	2.28e-05	0.000208	CcSEcCtD
Salbutamol—Body temperature increased—Timolol—coronary artery disease	2.28e-05	0.000208	CcSEcCtD
Salbutamol—Dizziness—Losartan—coronary artery disease	2.28e-05	0.000207	CcSEcCtD
Salbutamol—Vomiting—Furosemide—coronary artery disease	2.27e-05	0.000207	CcSEcCtD
Salbutamol—Rash—Furosemide—coronary artery disease	2.25e-05	0.000205	CcSEcCtD
Salbutamol—Dermatitis—Furosemide—coronary artery disease	2.25e-05	0.000205	CcSEcCtD
Salbutamol—Nausea—Captopril—coronary artery disease	2.25e-05	0.000205	CcSEcCtD
Salbutamol—Headache—Furosemide—coronary artery disease	2.24e-05	0.000204	CcSEcCtD
Salbutamol—Feeling abnormal—Lisinopril—coronary artery disease	2.21e-05	0.000201	CcSEcCtD
Salbutamol—Gastrointestinal pain—Lisinopril—coronary artery disease	2.19e-05	0.000199	CcSEcCtD
Salbutamol—Vomiting—Losartan—coronary artery disease	2.19e-05	0.000199	CcSEcCtD
Salbutamol—Nausea—Perindopril—coronary artery disease	2.18e-05	0.000199	CcSEcCtD
Salbutamol—Hypersensitivity—Ramipril—coronary artery disease	2.18e-05	0.000198	CcSEcCtD
Salbutamol—Rash—Losartan—coronary artery disease	2.17e-05	0.000198	CcSEcCtD
Salbutamol—Dermatitis—Losartan—coronary artery disease	2.17e-05	0.000198	CcSEcCtD
Salbutamol—Headache—Losartan—coronary artery disease	2.16e-05	0.000196	CcSEcCtD
Salbutamol—Urticaria—Lisinopril—coronary artery disease	2.13e-05	0.000194	CcSEcCtD
Salbutamol—Hypersensitivity—Timolol—coronary artery disease	2.13e-05	0.000194	CcSEcCtD
Salbutamol—Nausea—Furosemide—coronary artery disease	2.12e-05	0.000193	CcSEcCtD
Salbutamol—Asthenia—Ramipril—coronary artery disease	2.12e-05	0.000193	CcSEcCtD
Salbutamol—Body temperature increased—Lisinopril—coronary artery disease	2.12e-05	0.000193	CcSEcCtD
Salbutamol—Abdominal pain—Lisinopril—coronary artery disease	2.12e-05	0.000193	CcSEcCtD
Salbutamol—Pruritus—Ramipril—coronary artery disease	2.09e-05	0.00019	CcSEcCtD
Salbutamol—Asthenia—Timolol—coronary artery disease	2.07e-05	0.000189	CcSEcCtD
Salbutamol—Nausea—Losartan—coronary artery disease	2.05e-05	0.000186	CcSEcCtD
Salbutamol—Pruritus—Timolol—coronary artery disease	2.04e-05	0.000186	CcSEcCtD
Salbutamol—Diarrhoea—Ramipril—coronary artery disease	2.02e-05	0.000184	CcSEcCtD
Salbutamol—Diarrhoea—Timolol—coronary artery disease	1.98e-05	0.00018	CcSEcCtD
Salbutamol—Hypersensitivity—Lisinopril—coronary artery disease	1.97e-05	0.00018	CcSEcCtD
Salbutamol—Dizziness—Ramipril—coronary artery disease	1.95e-05	0.000178	CcSEcCtD
Salbutamol—Asthenia—Lisinopril—coronary artery disease	1.92e-05	0.000175	CcSEcCtD
Salbutamol—Dizziness—Timolol—coronary artery disease	1.91e-05	0.000174	CcSEcCtD
Salbutamol—Pruritus—Lisinopril—coronary artery disease	1.9e-05	0.000173	CcSEcCtD
Salbutamol—Vomiting—Ramipril—coronary artery disease	1.88e-05	0.000171	CcSEcCtD
Salbutamol—Rash—Ramipril—coronary artery disease	1.86e-05	0.00017	CcSEcCtD
Salbutamol—Dermatitis—Ramipril—coronary artery disease	1.86e-05	0.000169	CcSEcCtD
Salbutamol—Headache—Ramipril—coronary artery disease	1.85e-05	0.000168	CcSEcCtD
Salbutamol—Vomiting—Timolol—coronary artery disease	1.84e-05	0.000167	CcSEcCtD
Salbutamol—Diarrhoea—Lisinopril—coronary artery disease	1.83e-05	0.000167	CcSEcCtD
Salbutamol—Rash—Timolol—coronary artery disease	1.82e-05	0.000166	CcSEcCtD
Salbutamol—Dermatitis—Timolol—coronary artery disease	1.82e-05	0.000166	CcSEcCtD
Salbutamol—Headache—Timolol—coronary artery disease	1.81e-05	0.000165	CcSEcCtD
Salbutamol—Dizziness—Lisinopril—coronary artery disease	1.77e-05	0.000161	CcSEcCtD
Salbutamol—Nausea—Ramipril—coronary artery disease	1.76e-05	0.00016	CcSEcCtD
Salbutamol—Nausea—Timolol—coronary artery disease	1.72e-05	0.000156	CcSEcCtD
Salbutamol—Vomiting—Lisinopril—coronary artery disease	1.7e-05	0.000155	CcSEcCtD
Salbutamol—Rash—Lisinopril—coronary artery disease	1.69e-05	0.000154	CcSEcCtD
Salbutamol—Dermatitis—Lisinopril—coronary artery disease	1.69e-05	0.000154	CcSEcCtD
Salbutamol—Headache—Lisinopril—coronary artery disease	1.68e-05	0.000153	CcSEcCtD
Salbutamol—Nausea—Lisinopril—coronary artery disease	1.59e-05	0.000145	CcSEcCtD
Salbutamol—CYP3A4—Metabolism—AK1—coronary artery disease	6.17e-06	0.000238	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLAT—coronary artery disease	6.12e-06	0.000236	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	6.03e-06	0.000233	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	6.03e-06	0.000233	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	6.02e-06	0.000232	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—F2—coronary artery disease	6e-06	0.000232	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	5.98e-06	0.000231	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	5.92e-06	0.000229	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLCD1—coronary artery disease	5.92e-06	0.000228	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MDH2—coronary artery disease	5.92e-06	0.000228	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPAT—coronary artery disease	5.92e-06	0.000228	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UGCG—coronary artery disease	5.92e-06	0.000228	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	5.9e-06	0.000228	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	5.9e-06	0.000228	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	5.9e-06	0.000228	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	5.89e-06	0.000227	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—F2—coronary artery disease	5.87e-06	0.000227	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	5.85e-06	0.000226	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	5.79e-06	0.000224	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	5.78e-06	0.000223	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	5.77e-06	0.000223	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PGM1—coronary artery disease	5.7e-06	0.00022	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	5.65e-06	0.000218	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	5.5e-06	0.000212	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CKB—coronary artery disease	5.5e-06	0.000212	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PYGB—coronary artery disease	5.5e-06	0.000212	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	5.49e-06	0.000212	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	5.47e-06	0.000211	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	5.47e-06	0.000211	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	5.46e-06	0.000211	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	5.38e-06	0.000208	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	5.37e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	5.35e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	5.35e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	5.35e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	5.34e-06	0.000206	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	5.34e-06	0.000206	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	5.33e-06	0.000206	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLG—coronary artery disease	5.32e-06	0.000205	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	5.24e-06	0.000202	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	5.22e-06	0.000201	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	5.22e-06	0.000201	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLG—coronary artery disease	5.2e-06	0.000201	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	5.18e-06	0.0002	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DLAT—coronary artery disease	5.17e-06	0.0002	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.17e-06	0.0002	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COX5B—coronary artery disease	5.17e-06	0.0002	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.17e-06	0.0002	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.17e-06	0.0002	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	5.11e-06	0.000197	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	5.11e-06	0.000197	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	5.1e-06	0.000197	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—S100B—coronary artery disease	5.08e-06	0.000196	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	5.03e-06	0.000194	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	5e-06	0.000193	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	4.99e-06	0.000193	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	4.99e-06	0.000192	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	4.97e-06	0.000192	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	4.97e-06	0.000192	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—S100B—coronary artery disease	4.97e-06	0.000192	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	4.92e-06	0.00019	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SULT1E1—coronary artery disease	4.9e-06	0.000189	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	4.87e-06	0.000188	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	4.87e-06	0.000188	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	4.86e-06	0.000188	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	4.86e-06	0.000188	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	4.76e-06	0.000184	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	4.76e-06	0.000184	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOB—coronary artery disease	4.7e-06	0.000181	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.68e-06	0.000181	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HK2—coronary artery disease	4.68e-06	0.000181	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	4.66e-06	0.00018	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	4.64e-06	0.000179	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	4.62e-06	0.000178	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOB—coronary artery disease	4.6e-06	0.000177	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	4.59e-06	0.000177	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	4.56e-06	0.000176	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	4.54e-06	0.000175	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	4.52e-06	0.000175	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	4.52e-06	0.000174	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	4.52e-06	0.000174	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	4.49e-06	0.000173	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LPL—coronary artery disease	4.49e-06	0.000173	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.49e-06	0.000173	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	4.45e-06	0.000172	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	4.45e-06	0.000172	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	4.42e-06	0.000171	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	4.42e-06	0.000171	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.4e-06	0.00017	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LCAT—coronary artery disease	4.4e-06	0.00017	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LPL—coronary artery disease	4.39e-06	0.000169	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	4.35e-06	0.000168	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	4.35e-06	0.000168	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	4.33e-06	0.000167	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA4—coronary artery disease	4.32e-06	0.000167	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	4.24e-06	0.000164	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	4.23e-06	0.000163	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	4.21e-06	0.000162	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.17e-06	0.000161	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCLM—coronary artery disease	4.17e-06	0.000161	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	4.14e-06	0.00016	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	4.13e-06	0.00016	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	4.12e-06	0.000159	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	4.05e-06	0.000156	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	4.04e-06	0.000156	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—C3—coronary artery disease	4.04e-06	0.000156	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.04e-06	0.000156	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.04e-06	0.000156	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.98e-06	0.000154	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	3.96e-06	0.000153	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—C3—coronary artery disease	3.95e-06	0.000153	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.92e-06	0.000151	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HADH—coronary artery disease	3.92e-06	0.000151	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	3.85e-06	0.000149	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AGT—coronary artery disease	3.84e-06	0.000148	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	3.77e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOE—coronary artery disease	3.76e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—coronary artery disease	3.76e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AGT—coronary artery disease	3.76e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	3.72e-06	0.000144	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.72e-06	0.000143	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX2—coronary artery disease	3.72e-06	0.000143	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA2—coronary artery disease	3.72e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KDR—coronary artery disease	3.69e-06	0.000142	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—coronary artery disease	3.68e-06	0.000142	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOE—coronary artery disease	3.68e-06	0.000142	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.67e-06	0.000142	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.67e-06	0.000142	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HK1—coronary artery disease	3.67e-06	0.000142	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX4—coronary artery disease	3.67e-06	0.000142	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	3.66e-06	0.000141	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	3.64e-06	0.00014	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HADHA—coronary artery disease	3.63e-06	0.00014	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KDR—coronary artery disease	3.6e-06	0.000139	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	3.59e-06	0.000139	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.59e-06	0.000138	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	3.58e-06	0.000138	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—F2—coronary artery disease	3.55e-06	0.000137	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FN1—coronary artery disease	3.55e-06	0.000137	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPA—coronary artery disease	3.55e-06	0.000137	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	3.53e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	3.51e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	3.51e-06	0.000135	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—F2—coronary artery disease	3.47e-06	0.000134	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FN1—coronary artery disease	3.47e-06	0.000134	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	3.46e-06	0.000133	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.43e-06	0.000133	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	3.43e-06	0.000132	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA5—coronary artery disease	3.4e-06	0.000131	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KIT—coronary artery disease	3.39e-06	0.000131	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—P4HB—coronary artery disease	3.33e-06	0.000129	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KIT—coronary artery disease	3.32e-06	0.000128	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.27e-06	0.000126	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	3.26e-06	0.000126	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—coronary artery disease	3.23e-06	0.000125	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	3.23e-06	0.000125	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	3.19e-06	0.000123	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	3.16e-06	0.000122	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—coronary artery disease	3.16e-06	0.000122	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	3.16e-06	0.000122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	3.15e-06	0.000122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	3.11e-06	0.00012	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	3.09e-06	0.000119	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	3.09e-06	0.000119	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—VCAN—coronary artery disease	3.08e-06	0.000119	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	3.08e-06	0.000119	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.06e-06	0.000118	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	3.04e-06	0.000117	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	3.03e-06	0.000117	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DCN—coronary artery disease	2.97e-06	0.000115	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.96e-06	0.000114	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	2.95e-06	0.000114	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.89e-06	0.000112	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.89e-06	0.000112	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	2.89e-06	0.000111	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	2.86e-06	0.00011	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	2.82e-06	0.000109	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HBA1—coronary artery disease	2.82e-06	0.000109	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LIPC—coronary artery disease	2.82e-06	0.000109	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.82e-06	0.000109	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.82e-06	0.000109	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOC3—coronary artery disease	2.8e-06	0.000108	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	2.8e-06	0.000108	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LDLR—coronary artery disease	2.78e-06	0.000107	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	2.76e-06	0.000106	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.75e-06	0.000106	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.75e-06	0.000106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	2.74e-06	0.000106	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCLC—coronary artery disease	2.72e-06	0.000105	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CETP—coronary artery disease	2.72e-06	0.000105	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SDC1—coronary artery disease	2.69e-06	0.000104	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	2.68e-06	0.000104	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	2.68e-06	0.000103	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	2.63e-06	0.000101	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.54e-06	9.8e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.54e-06	9.8e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	2.5e-06	9.65e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CTGF—coronary artery disease	2.48e-06	9.57e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.46e-06	9.48e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT2—coronary artery disease	2.46e-06	9.48e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	2.45e-06	9.44e-05	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	2.41e-06	9.32e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	2.39e-06	9.23e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	2.38e-06	9.17e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	2.36e-06	9.12e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	2.34e-06	9.03e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	2.33e-06	8.99e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	2.33e-06	8.97e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	2.28e-06	8.79e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	2.26e-06	8.73e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.26e-06	8.72e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	2.21e-06	8.54e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	2.19e-06	8.46e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.19e-06	8.45e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	2.15e-06	8.28e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT1—coronary artery disease	2.12e-06	8.19e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GGT1—coronary artery disease	2.12e-06	8.19e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	2.03e-06	7.84e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.99e-06	7.66e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.91e-06	7.35e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.89e-06	7.29e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.88e-06	7.25e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.86e-06	7.19e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAT—coronary artery disease	1.85e-06	7.16e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.83e-06	7.05e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.82e-06	7.03e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOB—coronary artery disease	1.8e-06	6.95e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.79e-06	6.9e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.75e-06	6.76e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPL—coronary artery disease	1.72e-06	6.63e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX1—coronary artery disease	1.68e-06	6.47e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CD36—coronary artery disease	1.63e-06	6.3e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.61e-06	6.22e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.59e-06	6.12e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.55e-06	5.99e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.55e-06	5.97e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AGT—coronary artery disease	1.47e-06	5.68e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOE—coronary artery disease	1.44e-06	5.56e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA1—coronary artery disease	1.42e-06	5.5e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—coronary artery disease	1.4e-06	5.42e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.37e-06	5.3e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.3e-06	5e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.27e-06	4.89e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARG—coronary artery disease	1.25e-06	4.84e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—coronary artery disease	1.24e-06	4.78e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—coronary artery disease	1.13e-06	4.36e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—coronary artery disease	1.08e-06	4.17e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.87e-07	3.81e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.07e-07	2.34e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKT1—coronary artery disease	4.96e-07	1.91e-05	CbGpPWpGaD
